AixThera

Overview

AixThera is a venture capital firm investing in the development of new therapeutics with the potential to positively impact patient lives. The firm focuses on healthcare and biotechnology sectors, aiming to support innovative companies that can make a significant difference in patient care. Their investment strategy includes early to late-stage funding, with investments ranging from €5 million to €20 million per company. AixThera's geographical focus spans across Europe and North America, targeting countries such as France, the United States, Ireland, the United Kingdom, Germany, the Netherlands, Sweden, Denmark, Italy, Spain, Belgium, Switzerland, Austria, Norway, Finland, Portugal, Poland, the Czech Republic, Hungary, and Romania. The firm's portfolio encompasses a diverse range of industries, including healthcare, biotechnology, pharmaceuticals, medical devices, diagnostics, digital health, medical research, clinical trials, health IT, medical equipment, biotech research, pharmaceutical research, medtech, health services, and biotech manufacturing. AixThera's mission is to identify and support companies that are developing innovative therapeutics, aiming to bring impactful solutions to the healthcare market. By providing substantial funding and strategic guidance, the firm seeks to accelerate the growth of its portfolio companies, enabling them to bring their products to market more efficiently and effectively. Through its investments, AixThera contributes to the advancement of medical treatments and technologies, striving to improve patient outcomes and quality of life. The firm's experienced team, led by CEO Seamus Mulligan, brings a wealth of knowledge and expertise in the pharmaceutical and biotechnology industries, positioning AixThera as a key player in the venture capital landscape focused on healthcare innovation.

Investment Focus

• Innovative therapeutics
• Positive impact on patient lives
• Healthcare and biotechnology sectors
• Early to late-stage companies
• Investment size between €5 million and €20 million
• Geographical focus on Europe and North America
• Diverse industries including healthcare, biotechnology, pharmaceuticals, medical devices, diagnostics, digital health, medical research, clinical trials, health IT, medical equipment, biotech research, pharmaceutical research, medtech, health services, and biotech manufacturing

Portfolio Companies